Diligence memo · auto-generated · as of July 3, 2026
Rarebird, Inc.
Rarebird, Inc. looks under-valued against its niche peers and is quiet on financing cadence.
Businessfiled
Rarebird, Inc. operates in Retailing, based in SAN FRANCISCO, CA, USA. Elevating mental health to be a part of your daily coffee ritual.
Sub-sector tags: Healthcare, Industrial Bio.
Capital & rounds (filed)filed
Rarebird, Inc. has raised $9.0M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $6.5M on 2023-07-14.
Most recent recorded round closed around 2024-10-11.
Valuation (modeled)modeled
Provath models Rarebird, Inc. at approximately $2.9M (range $1.2M–$5.8M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.16× the median modeled value of Series A Retailing companies in 2022–2024 (100 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 4 months.
Last raise 21 mo ago; this sector typically re-raises about every 13 months.
Slightly overdue versus sector cadence.
The last round stepped up 10.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 79% of Retailing peers (2347 compared).
Modeled value ranks above 35% of those peers.
Closest niche peers: Olivela Inc., PSP Investors, LLC, Coreleap, Inc., Cariloha, Inc., Elevation Cannabis, LLC.
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.